Gw&K Investment Management, LLC Chemo Centryx, Inc. Transaction History

Gw&K Investment Management, LLC

$11.7 Billion
Q3 2024

Shares

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 09, 2022	SELL	$22.17 - $51.8 $18.9 Million - $44.2 Million	-853,175 Reduced 55.51%	683,702 $35.3 Million
Q2 2022 Aug 09, 2022	BUY	$15.36 - $27.51 $5.77 Million - $10.3 Million	375,530 Added 32.34%	1,536,877 $38.1 Million
Q1 2022 May 09, 2022	BUY	$22.22 - $39.12 $11.3 Million - $19.9 Million	509,151 Added 78.07%	1,161,347 $29.1 Million
Q4 2021 Feb 11, 2022	BUY	$18.38 - $40.5 $12 Million - $26.4 Million	652,196 New	652,196 $23.7 Million

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gw&K Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gw&K Investment Management, LLC with notifications on news.